Key result
Aminoguanidine fails to improve left ventricular developed pressure in endotoxemia despite reducing serum nitrites.
Why the study?
Does aminoguanidine prevent cardiac depression in a rat model of acute endotoxemia?
RCT (n=20)
Randomly selected
Does aminoguanidine prevent cardiac depression in a rat model of acute endotoxemia?
Selective inhibition of iNOS with aminoguanidine reduces NO production but does not prevent early-stage cardiac dysfunction in acute endotoxemia.
iNOS inhibition fails to rescue cardiac function in acute endotoxemia; hypothesis-generating for alternative pathways in septic cardiomyopathy.
This study evaluates the effect of aminoguanidine, a preferential inhibitor of inducible nitric oxide synthase (iNOS), on the prevention of cardiac depression in acute endotoxemia. Cardiac performance was evaluated after 4 h of exposure to endotoxin. Rats (n = 5) were selected randomly to receive, by intraperitoneal injection, one of four treatments: saline, LPS (lipopolysaccharide, E. coli, 4 mg/kg, AG (aminoguanidine 100 mg/kg), and LPS + AG at various times. AG and saline treatments were administered 30 min before LPS and at 1 and 3 h after LPS injection. Hearts were perfused using the Langendorff isolated perfusion system and a balloon-tipped catheter was placed into the left ventricle to measure left ventricular developed pressure (LVDP). Myocyte contractile function was assessed with electrical field stimulation and video microscopy. Tissue was immunostained for the expression of iNOS and for nitrotyrosine, a byproduct of protein nitration by peroxynitrite. Perfused hearts from LPS-treated rats exhibited a 57% decrease (P < 0.05) in LVDP compared to saline-treated animals. No improvement in ventricular function was observed with the administration of AG. Similarly, cardiac myocytes prepared from LPS-treated animals demonstrated a significant (P < 0.05) reduction in percent and velocity of shortening and this effect was unaltered with the same dose of AG. AG administration significantly reduced serum nitrite/nitrate levels (P < 0.05) in endotoxemic rats to control levels. Localized expression of iNOS in the myocardium was lessened with AG treatment and was not associated with peroxynitrite formation in this model of endotoxemia. The results indicate that AG given in vivo before and after endotoxin (at a concentration sufficient to decrease NO production) did not reduce cardiac depression. We conclude that selective inhibition of iNOS and the reduction of NO production do not prevent cardiac dysfunction at an early stage in an acute model of endotoxemia.
No takes yet. Share an insight, caveat, or question.
Vona‐Davis et al. (2002) conducted an RCT in Acute endotoxemia (n=20). Aminoguanidine vs. Saline was evaluated on Left ventricular developed pressure (LVDP). Aminoguanidine did not improve the 57% decrease in left ventricular developed pressure caused by endotoxemia, despite significantly reducing serum nitrite/nitrate levels (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: